Extract
Asthma is the most common medical condition in athletes, with a reported prevalence of approximately 20% [1]. Over the past two decades, the impact of asthma on athletic performance has been extensively studied [2]; however, research focussing specifically on asthma-related death in athletes is limited to one study, with Becker et al. [3] reporting a series of 61 deaths over a 7-year period (1993–2000), either during or in close proximity with a sporting event. We therefore undertook this study to provide comprehensive insight into the incidence of asthma-related mortality in competitive athletes.
Abstract
Asthma remains a rare but important cause of sudden death in young athletes. Approximately one athlete with asthma died per year, thus highlighting that with appropriate medical management, sports participation for people with asthma is generally safe. https://bit.ly/3r9dE5t
Footnotes
Author contributions: Conception and design: O.J. Price, K.L. Kucera, J.A. Drezner and J.H. Hull; analysis and interpretation: O.J. Price and J.H. Hull; drafting the manuscript for important intellectual content: O.J. Price, K.L. Kucera, H.M. Price, J.A. Drezner, A. Menzies-Gow and J.H. Hull. O.J. Price and J.H. Hull confirm full responsibility for the content of the manuscript.
Conflict of interest: O.J. Price has nothing to disclose.
Conflict of interest: K.L. Kucera reports other (research donation to NCCSIR) from National Athletic Trainers' Association, American Football Coaches Association, American Medical Society for Sports Medicine and National Operating Committee on Standards in Athletic Equipment, other (service agreement to NCCSIR for surveillance) from National Collegiate Athletic Association and National Federation of State High School Associations, outside the submitted work.
Conflict of interest: H.M. Price has nothing to disclose.
Conflict of interest: J.A. Drezner has nothing to disclose.
Conflict of interest: A. Menzies-Gow reports grants and personal fees from AstraZeneca, personal fees and other (support for attendance at international conference) from Teva, personal fees from GlaxoSmithKline, Novartis, Vectura and Sanofi, outside the submitted work.
Conflict of interest: J.H. Hull has nothing to disclose.
Support statement: The National Center for Catastrophic Sports Injury Research (University of North Carolina at Chapel Hill) is funded by the National Collegiate Athletic Association, the National Federation of State High School Associations, the American Football Coaches Association, the National Athletic Trainers’ Association, the National Operating Committee on Standards for Athletic Equipment, and the American Medical Society for Sports Medicine.
- Received January 12, 2021.
- Accepted February 24, 2021.
- Copyright ©The authors 2021. For reproduction rights and permissions contact permissions{at}ersnet.org